| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.62B | 10.23B | 9.32B | 7.79B | 4.19B | 2.94B |
| Gross Profit | 9.75B | 9.19B | 8.29B | 6.87B | 3.41B | 2.31B |
| EBITDA | 9.42B | 9.09B | 7.99B | 6.60B | 3.11B | 2.09B |
| Net Income | 1.04B | 984.00M | 755.00M | 600.00M | 380.00M | 308.00M |
Balance Sheet | ||||||
| Total Assets | 218.75B | 203.24B | 150.14B | 128.25B | 115.14B | 109.11B |
| Cash, Cash Equivalents and Short-Term Investments | 58.50B | 4.96B | 3.63B | 3.75B | 3.44B | 2.40B |
| Total Debt | 32.03B | 19.00M | 16.26B | 11.36B | 8.96B | 11.80B |
| Total Liabilities | 197.49B | 182.77B | 133.54B | 114.18B | 103.53B | 98.89B |
| Stockholders Equity | 5.58B | 5.36B | 4.28B | 3.58B | 2.85B | 2.40B |
Cash Flow | ||||||
| Free Cash Flow | 32.63B | 15.74B | 8.68B | 4.50B | 3.90B | 5.82B |
| Operating Cash Flow | 32.71B | 15.81B | 8.72B | 4.54B | 3.97B | 5.90B |
| Investing Cash Flow | -1.45B | -171.00M | -44.00M | -52.00M | -67.00M | -188.00M |
| Financing Cash Flow | -1.06B | -969.00M | -833.00M | -624.00M | -470.00M | -523.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $25.07B | 30.48 | 13.64% | 0.45% | 18.26% | 66.10% | |
78 Outperform | $37.40B | 19.07 | 24.63% | 1.06% | 10.61% | 53.46% | |
77 Outperform | $36.24B | 27.97 | 19.89% | 0.46% | 12.92% | 28.20% | |
71 Outperform | $29.52B | 13.05 | 17.21% | 1.26% | 5.83% | 1.44% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $24.31B | 23.29 | 20.98% | 1.14% | 0.92% | ― | |
62 Neutral | $22.86B | 16.91 | 17.04% | 0.32% | 38.08% | -22.75% |